公开(公告)号：US09974325B2

公开(公告)日：2018-05-22

申请号：US15425601

申请日：2017-02-06

申请人： Philip Morris USA Inc.

发明人： Danielle R. Crawford ,  Shon Gedevani ,  William R. Sweeney ,  Chris Irving

IPC分类号： A61L15/16 ,  A23L27/00 ,  A23L29/212 ,  A23L29/25 ,  A23L29/256 ,  A23L33/15 ,  A23P10/30 ,  A23P30/10

CPC分类号： A23L27/72 ,  A23L29/212 ,  A23L29/25 ,  A23L29/256 ,  A23L33/15 ,  A23P10/30 ,  A23P30/10 ,  A23V2002/00

摘要： An oral product includes a matrix including a mixture of a plurality of capsules, a powdered component, a viscous component and a binder and wherein the matrix is molded into a shape. In a preferred embodiment, the capsules provide functional and flavorful ingredients. In an embodiment, the matrix is enclosed in a porous material that forms a pouch.

公开(公告)号：US20180125913A1

公开(公告)日：2018-05-10

申请号：US15575555

申请日：2016-05-19

申请人： Ralco Nutrition, Inc.

发明人： Richard Dale LAMB

IPC分类号： A61K36/53 ,  A23K10/30 ,  A23K50/30 ,  A23K50/70 ,  A23K50/75 ,  A23K50/80 ,  A61K9/107 ,  A61K9/00 ,  A61K9/48 ,  A61K36/54 ,  A61K31/05 ,  A61K31/11

CPC分类号： A61K36/53 ,  A23K10/30 ,  A23K20/111 ,  A23K50/30 ,  A23K50/70 ,  A23K50/75 ,  A23K50/80 ,  A23L27/10 ,  A23L29/10 ,  A23L29/25 ,  A23L33/105 ,  A61K9/0014 ,  A61K9/0053 ,  A61K9/107 ,  A61K9/48 ,  A61K31/05 ,  A61K31/11 ,  A61K36/54 ,  A61K2300/00

摘要： In general, embodiments of the present invention essential oil animal treatment compositions, and methods of making and using such products and compositions. The compositions comprise an essential oil fraction include including oregano essential oil, thyme essential oil, and cinnamon essential oil. The compositions can optionally include one or more emulsifiers and be in the form of an emulsion. An emulsifier can include arabinogalactan. The use of these products and compositions can enhance the health and feed efficiency of animals.

公开(公告)号：US20180069078A1

公开(公告)日：2018-03-08

申请号：US15808889

申请日：2017-11-10

申请人： PoViva Tea, LLC

发明人： Michelle Reillo ,  Marian E. Washington

IPC分类号： H01L29/06 ,  H01L29/78 ,  H01L29/775 ,  H01L29/66 ,  H01L29/423 ,  B82Y10/00 ,  H01L21/8238 ,  H01L21/02 ,  H01L27/092

CPC分类号： H01L29/0673 ,  A23C9/156 ,  A23C9/16 ,  A23F3/405 ,  A23L2/52 ,  A23L3/44 ,  A23L27/84 ,  A23L29/035 ,  A23L29/25 ,  A23L33/105 ,  A23L33/115 ,  A23L33/15 ,  A23V2002/00 ,  A61K9/0056 ,  A61K9/0095 ,  A61K9/148 ,  A61K31/05 ,  A61K31/167 ,  A61K31/192 ,  A61K31/196 ,  A61K31/352 ,  A61K31/355 ,  A61K31/405 ,  A61K31/455 ,  A61K31/465 ,  A61K31/5415 ,  A61K31/616 ,  A61K31/621 ,  A61K36/185 ,  A61K36/82 ,  A61K47/44 ,  A61K47/46 ,  B82Y10/00 ,  H01L21/02381 ,  H01L21/02461 ,  H01L21/02532 ,  H01L21/02603 ,  H01L21/823807 ,  H01L27/092 ,  H01L29/42376 ,  H01L29/42392 ,  H01L29/66439 ,  H01L29/66545 ,  H01L29/66795 ,  H01L29/775 ,  H01L29/785 ,  A61K2300/00

摘要： Aspects described herein relate to food and beverage compositions infused with lipophilic active agents and methods of use for the treatment of a variety of disorders. More particularly, aspects described herein relate to food and beverage compositions infused with lipophilic active agents such as cannabinoids, nicotine, nonsteroidal anti-inflammatories (NSAIDs), and vitamins, that provide enhanced bioavailability of the lipophilic active agents in a subject, and that mask unpleasant tastes of lipophilic active agents.

公开(公告)号：US20180027834A1

公开(公告)日：2018-02-01

申请号：US15548964

申请日：2016-02-08

申请人： BASF SE

发明人： Nina MUSAEUS ,  Inge-Lise KRYLBO

IPC分类号： A23C9/152 ,  A23L29/25 ,  A23P10/30 ,  C09B61/00 ,  A61K9/20 ,  A61K9/50 ,  C09B67/02 ,  A23L33/105 ,  A61K31/047

CPC分类号： A23C9/152 ,  A23K20/10 ,  A23K20/158 ,  A23K20/163 ,  A23K20/179 ,  A23L2/52 ,  A23L2/58 ,  A23L5/44 ,  A23L29/25 ,  A23L33/105 ,  A23P10/30 ,  A23V2002/00 ,  A61K9/2081 ,  A61K9/5036 ,  A61K9/5089 ,  A61K31/047 ,  A61K31/65 ,  C09B61/00 ,  C09B67/0097

摘要： The invention relates to microcapsules comprising at least one active substance selected from lutein and lutein esters embedded in a matrix comprising gum acacia and optionally one or more other matrix components, wherein the content of said at least one active substance calculated as free lutein is from 0.5 to 25% of total weight of the microcapsule, and which microcapsule does not comprise any added emulsifier.The invention further relates to a process of preparing the microcapsule as well as uses and products comprising the microcapsule.

公开(公告)号：US20170311632A1

公开(公告)日：2017-11-02

申请号：US15520237

申请日：2015-10-20

申请人： INTERNATIONAL FLAVORS & FRAGRANCES INC.

发明人： Ying YANG ,  Daniel Kaiping LEE ,  Chii-Fen WANG

IPC分类号： A23L2/56 ,  A23L27/00 ,  C12G3/06

CPC分类号： A23D7/01 ,  A23D7/005 ,  A23J7/00 ,  A23L2/385 ,  A23L2/56 ,  A23L27/2026 ,  A23L27/34 ,  A23L27/80 ,  A23L29/035 ,  A23L29/10 ,  A23L29/231 ,  A23L29/238 ,  A23L29/25 ,  A23L29/27 ,  A23V2002/00 ,  A23V2250/1842 ,  A23V2250/1846 ,  A23V2250/5022 ,  A23V2250/506 ,  A23V2250/5072 ,  A23V2250/5086 ,  A23V2250/6402 ,  A23V2250/6412 ,  A23V2250/6418 ,  A23V2250/642 ,  A23V2250/6422 ,  C11B9/00 ,  C12G3/06

摘要： A method of preparing a lysolecithin composition. The method includes the steps of (a) providing a lecithin mixture including a lecithin, water, and ethanol, (b) adding phospholipase A1 or A2 to the lecithin mixture; and (c) allowing an enzymatic reaction to occur so that at least 70% of the phospholipids in the lecithin are converted to lysophospholipids to obtain the lysolecithin composition. Also disclosed are a lysolecithin composition thus prepared, a flavor emulsion prepared from the lysolecithin composition, and a liquid beverage or liquid beverage concentrate containing the lysolecithin composition.

公开(公告)号：US09795154B2

公开(公告)日：2017-10-24

申请号：US14358044

申请日：2012-12-12

申请人： Rudolf Wild GmbH & Co. KG

发明人： Thomas Heidebach ,  Matthias Sass ,  Axel De With

IPC分类号： A23L1/053 ,  A23L2/52 ,  C12P19/02 ,  C12P19/14 ,  A23L29/25

CPC分类号： A23L29/25 ,  A23L2/52 ,  C12P19/02 ,  C12P19/14

摘要： The present invention relates to a method for preparing modified gum arabic comprising treating gum arabic with an enzyme selected from the group of glycosidases at a concentration of 1 to 1000 units of enzyme per gram of gum arabic, a modified gum arabic obtainable by said method, an emulsion comprising the modified gum arabic and a beverage concentrate and ready-to-drink beverage comprising the emulsion.

公开(公告)号：US20170143023A1

公开(公告)日：2017-05-25

申请号：US15425601

申请日：2017-02-06

申请人： Philip Morris USA Inc.

发明人： Danielle R. Crawford ,  Shalva Gedevanishvili ,  William R. Sweeney ,  Chris Irving

IPC分类号： A23L27/00 ,  A23L29/25 ,  A23P30/10 ,  A23L33/15 ,  A23P10/30 ,  A23L29/212 ,  A23L29/256

CPC分类号： A23L27/72 ,  A23L29/212 ,  A23L29/25 ,  A23L29/256 ,  A23L33/15 ,  A23P10/30 ,  A23P30/10 ,  A23V2002/00

摘要： An oral product includes a matrix including a mixture of a plurality of capsules, a powdered component, a viscous component and a binder and wherein the matrix is molded into a shape. In a preferred embodiment, the capsules provide functional and flavorful ingredients. In an embodiment, the matrix is enclosed in a porous material that forms a pouch.

公开(公告)号：US20170128510A1

公开(公告)日：2017-05-11

申请号：US14983691

申请日：2015-12-30

申请人： LOëN HOLDING S.A.R.L.

发明人： Lionel Roland Courtot

IPC分类号： A61K36/288 ,  B65D75/36 ,  A61K36/28 ,  A61K9/00 ,  A61K36/185

CPC分类号： A61K36/288 ,  A23L29/25 ,  A23L29/256 ,  A23L33/105 ,  A61K9/0053 ,  A61K36/185 ,  A61K36/28 ,  B65D75/36

摘要： Preparation process for dietary supplements, comprising at least two steps, the first step of which is to obtain a basic composition comprising liquid vegetable extracts (that contain alcohol), essential oils, water and optionally powdered vegetable extracts, mineral elements, vitamins, vegetable oils, marine plasma, organic silica, etc., and the second step of which is used to solidify the mixture by adding a solidifying premix comprising alginates, a vegetable gum and optionally solidification retarders such as dry hydrophilic plants, water chelators or other substances, even chemicals. The advantage of the process is that it enables dietary supplements to be obtained in a dry solid state that can be stored at ambient temperature or in a refrigerator, and is stable over time, without losing the nutritional and therapeutic value of the vegetable or natural substances contained therein.

公开(公告)号：US20170079926A1

公开(公告)日：2017-03-23

申请号：US15139262

申请日：2016-04-26

申请人： SLENDINE SA

发明人： Paolo Costa

IPC分类号： A61K9/48 ,  A61F5/00

CPC分类号： A61K9/4808 ,  A23L2/52 ,  A23L29/25 ,  A23L33/21 ,  A23L33/30 ,  A61F5/0076 ,  A61K9/2072 ,  A61K9/4825 ,  A61K9/4866

摘要： The present invention provides compositions, devices; and methods for affecting, among other things, weight loss and/or weight control, by sequestering nutrients or other compounds such as toxins from absorption in the digestive tract. The compositions, devices, and methods employ one or more members made of a compressible, absorbent matrix material. In various embodiments, the matrix material is suitable for routine use. The compressible absorbent matrix material has a size, shape and/or geometry configured for efficient packing into a small space, and/or configured to absorb and substantially retain digested material in the stomach. The devices and compositions may further comprise one or more hydrogel(s), soluble or insoluble fibers, waxes and/or gums to provide the desired mechanical properties and/or absorptive or shielding properties.

公开(公告)号：US20160243202A1

公开(公告)日：2016-08-25

申请号：US14661526

申请日：2015-03-18

申请人： International Nutrition Research Company

发明人： Claude Vincent

IPC分类号： A61K38/44 ,  A61K31/405 ,  A61K31/145 ,  A61K31/715 ,  A61K31/733 ,  A61K38/16 ,  A61K31/59 ,  A61K31/519 ,  A61K31/675 ,  A61K31/355 ,  A61K31/202 ,  A61K31/14 ,  A61K31/198 ,  A61K31/714

CPC分类号： A61K38/446 ,  A23L29/25 ,  A23L33/15 ,  A23L33/155 ,  A23L33/16 ,  A23L33/17 ,  A23L33/175 ,  A23L33/185 ,  A23L33/20 ,  A23L33/30 ,  A23L33/40 ,  A61K31/12 ,  A61K31/14 ,  A61K31/145 ,  A61K31/185 ,  A61K31/198 ,  A61K31/202 ,  A61K31/355 ,  A61K31/405 ,  A61K31/4415 ,  A61K31/519 ,  A61K31/59 ,  A61K31/675 ,  A61K31/714 ,  A61K31/715 ,  A61K31/733 ,  A61K33/00 ,  A61K35/20 ,  A61K36/48 ,  A61K36/74 ,  A61K36/88 ,  A61K38/011 ,  A61K38/018 ,  A61K38/063 ,  A61K38/168 ,  A61K38/44 ,  C12Y111/01006 ,  C12Y115/01001 ,  A61K2300/00

摘要： The invention relates to an orally administered drug or medical nutrition composition for use in the prevention or treatment of metabolic steatosis and steatohepatitis of abdominally obese people with metabolic syndrome.The composition comprises at least: proteins and/or free amino adds, fibers selected at least from acacia gum fibers and/or fructooligosaccharide fibers, vitamins D, B6, B9, B12 and E, omega 3 in the form of ALA, glutathione, SOD, catalase, choline.

摘要翻译： 本发明涉及用于预防或治疗具有代谢综合征的腹部肥胖人的代谢脂肪变性和脂肪性肝炎的口服药物或医疗营养组合物。 所述组合物至少包含：至少从阿拉伯树胶纤维和/或低聚果糖纤维中选择的蛋白质和/或游离氨基添加剂，ALA，谷胱甘肽，SOD形式的维生素D，B6，B9，B12和E，ω3 ，过氧化氢酶，胆碱。